EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Randomisierte kontrollierte Studie

Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults

Alberto Papi iD, Michael G Ison iD, Joanne M Langley, Dong-Gun Lee, Isabel Leroux-Roels, Federico Martinon-Torres, Tino F Schwarz, Richard N van Zyl-Smit, Laura Campora, Nancy Dezutter, Nathalie de Schrevel, Laurence Fissette und 5 weitere

New England Journal of Medicine · 16.02.2023 · 388 (7) · 595-608

DOI: 10.1056/nejmoa2209604 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 16.02.2023. Verfasst von Alberto Papi und 16 weiteren Autor:innen. Beteiligte Einrichtung: From the Pulmonary Division, University of Ferrara, St. Anna University Hospital, Ferrara, Italy (A.P.); the Divisions of Infectious Diseases and Org…. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines, Respiratory Syncytial Virus, Human, Respiratory Tract Infections. Die Arbeit wurde bisher 812-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: GlaxoSmithKline Biologicals SA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesRespiratory Syncytial Virus, HumanRespiratory Tract InfectionsAgedHumansAdjuvants, ImmunologicAntibodies, ViralInternationalityVaccine Efficacy

Substanzen

Adjuvants, ImmunologicAntibodies, ViralRespiratory Syncytial Virus Vaccines

Autor:innen und Institutionen

  • From the Pulmonary Division, University of Ferrara, St. Anna University Hospital, Ferrara, Italy (A.P.); the Divisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicin…

ORCID-Profile: Alberto Papi, Michael G Ison

Förderung

  • GlaxoSmithKline Biologicals SA

Zitieren

APA

Papi, A., Ison, M. G., Langley, J. M., Lee, D. G., Leroux-Roels, I., Martinon-Torres, F., Schwarz, T. F., van Zyl-Smit, R. N., Campora, L., Dezutter, N., de Schrevel, N., Fissette, L., David, M. P., Van der Wielen, M., Kostanyan, L., Hulstrøm, V., & AReSVi-006 Study Group (2023). Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults. New England Journal of Medicine, 388(7), 595-608. https://doi.org/10.1056/nejmoa2209604

Vancouver

Papi A, Ison MG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, et al. Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults. New England Journal of Medicine. 2023;388(7):595-608. doi:10.1056/nejmoa2209604

BibTeX
@article{Papi2023,
  author = {Papi, Alberto and Ison, Michael G and Langley, Joanne M and Lee, Dong-Gun and Leroux-Roels, Isabel and Martinon-Torres, Federico and Schwarz, Tino F and van Zyl-Smit, Richard N and Campora, Laura and Dezutter, Nancy and de Schrevel, Nathalie and Fissette, Laurence and David, Marie-Pierre and Van der Wielen, Marie and Kostanyan, Lusine and Hulstrøm, Veronica and AReSVi-006 Study Group, AReSVi-006 Study Group},
  title = {Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {388},
  number = {7},
  pages = {595--608},
  doi = {10.1056/nejmoa2209604}
}
Kostenlos starten →